Close
Form S-8 Apogee Therapeutics, May 13, 2024 07:27AM

As filed with the Securities and Exchange Commission on May 13, 2024

Registration No. 333-       

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM S-8

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

Apogee Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 93-4958665 (State or other jurisdiction of incorporation or organization) (I.R.S. ... (continue reading...)
Form 13F-NT Viola Growth Management For: Mar 31 May 13, 2024 07:27AM .FormData { color: blue; background-color: white; font-size: small; font-family: Times, serif; } .FormDataC { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center; } .FormDataR { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align:... (continue reading...)
Form 8-K BOYD GAMING CORP For: May 09 May 13, 2024 07:24AM false 0000906553 0000906553 2024-05-09 2024-05-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K __________________________   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (date of earliest event reported): May 9, 2024       Boyd Gaming Corporation (Exact Name of Registrant as Specified in its Charter)   Nevada ... (continue reading...)
Form 13F-NT Viola Ventures GP 3 Ltd. For: Mar 31 May 13, 2024 07:24AM .FormData { color: blue; background-color: white; font-size: small; font-family: Times, serif; } .FormDataC { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center; } .FormDataR { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align:... (continue reading...)
Form 8-K Autolus Therapeutics For: May 13 May 13, 2024 07:23AM 00-0000000 0001730463 false 0001730463 2024-05-13 2024-05-13 0001730463 sic:Z8880 2024-05-13 2024-05-13 0001730463 us-gaap:CommonClassAMember 2024-05-13 2024-05-13

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 13, 2024

 

 

Autolus Therapeutics plc

(Exact name of... (continue reading...)


More SEC Filings

View Older Stories

May 13, 2024 07:21AM Form 8-K AVANOS MEDICAL, INC. For: May 13
May 13, 2024 07:21AM Form 13F-HR Dunhill Financial, LLC For: Mar 31
May 13, 2024 07:20AM Form 13F-HR Viola Ventures V.C. Mana For: Mar 31
May 13, 2024 07:20AM Form SC TO-C INCYTE CORP Filed by: INCYTE CORP
May 13, 2024 07:19AM Form 13F-HR Handelsbanken Fonder AB For: Mar 31
May 13, 2024 07:19AM Form 6-K Gildan Activewear Inc. For: May 13
May 13, 2024 07:19AM Form 8-K INCYTE CORP For: May 12
May 13, 2024 07:16AM Form 10-Q Akoustis Technologies, For: Mar 31
May 13, 2024 07:16AM Form 10-Q PRECISION BIOSCIENCES For: Mar 31
May 13, 2024 07:16AM Form 10-Q Fulcrum Therapeutics, For: Mar 31
May 13, 2024 07:16AM Form 8-K ProPetro Holding Corp. For: May 09
May 13, 2024 07:15AM Form 8-K TScan Therapeutics, Inc. For: May 13
May 13, 2024 07:15AM Form 8-K Tourmaline Bio, Inc. For: May 13
May 13, 2024 07:15AM Form 8-K PRECISION BIOSCIENCES For: May 13
May 13, 2024 07:15AM Form 8-K Iterum Therapeutics plc For: May 13
May 13, 2024 07:12AM Form 10-Q/A CareMax, Inc. For: Mar 31
May 13, 2024 07:12AM Form 6-K Sendas Distributor S.A. For: Jun 30
May 13, 2024 07:11AM Form 10-Q Apogee Therapeutics, For: Mar 31
May 13, 2024 07:11AM Form 8-K LEAP THERAPEUTICS, INC. For: May 13
May 13, 2024 07:09AM Form 8-K MITEK SYSTEMS INC For: May 09
May 13, 2024 07:08AM Form S-1/A Bowhead Specialty Holdin
May 13, 2024 07:08AM Form 13F-HR LOGAN CAPITAL MANAGEMENT For: Mar 31
May 13, 2024 07:07AM Form 10-Q Boundless Bio, Inc. For: Mar 31
May 13, 2024 07:06AM Form 8-K Apogee Therapeutics, For: May 13
May 13, 2024 07:05AM Form 8-K Galera Therapeutics, For: May 13
May 13, 2024 07:05AM Form 8-K Boundless Bio, Inc. For: May 13
May 13, 2024 07:05AM Form 8-K Fulcrum Therapeutics, For: May 11
May 13, 2024 07:04AM Form 8-K D-Wave Quantum Inc. For: May 13
May 13, 2024 07:04AM Form 8-K Veradigm Inc. For: May 10
May 13, 2024 07:03AM Form 6-K Can-Fite BioPharma Ltd. For: May 13
May 13, 2024 07:03AM Form 8-K Squarespace, Inc. For: May 13
May 13, 2024 07:03AM Form 10-Q/A NextDecade Corp. For: Mar 31
May 13, 2024 07:03AM Form D Amet LLC
May 13, 2024 07:02AM Form 10-Q Mastech Digital, Inc. For: Mar 31
May 13, 2024 07:02AM Form 6-K Legend Biotech Corp For: Mar 31
May 13, 2024 07:02AM Form 6-K Burford Capital Ltd For: May 13
May 13, 2024 07:02AM Form 8-K NEWS CORP For: May 10
May 13, 2024 07:01AM Form 8-K iTeos Therapeutics, Inc. For: May 10
May 13, 2024 07:01AM Form 4 Nine Energy Service, For: May 09 Filed by: Crombie David
May 13, 2024 07:01AM Form 13F-HR DSM CAPITAL PARTNERS For: Mar 31
May 13, 2024 07:01AM Form NT 10-Q Veradigm Inc. For: Mar 31
May 13, 2024 07:01AM Form 6-K Zhihu Inc. For: May 13
May 13, 2024 07:00AM Form 15-15D Equifax do Brasil S.A.
May 13, 2024 07:00AM Form 6-K SMX (Security Matters) For: May 13
May 13, 2024 07:00AM Form 6-K Tiziana Life Sciences For: May 13
May 13, 2024 07:00AM Form 6-K Burford Capital Ltd For: May 13
May 13, 2024 07:00AM Form 4 Nine Energy Service, For: May 09 Filed by: Fox Ann G
May 13, 2024 07:00AM Form 10-Q Milestone Pharmaceutical For: Mar 31
May 13, 2024 06:59AM Form 4 Nine Energy Service, For: May 09 Filed by: Luz S. Brett
May 13, 2024 06:58AM Form 4 Nine Energy Service, For: May 09 Filed by: MOORE THEODORE R.
View Older Stories